These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8652896)

  • 21. Nicardipine as antihypertensive therapy in liver transplant recipients: results of long-term use.
    Duvoux C; Cherqui D; Di Martino V; Métreau JM; Salvat A; Lauzet JY; Fagniez PL; Dhumeaux D
    Hepatology; 1997 Feb; 25(2):430-3. PubMed ID: 9021959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrotoxic effects of immunosuppressant therapy in pediatric liver transplant recipients.
    McCulloch MI; Burger H; Spearman CW; Cooke L; Goddard E; Gajjar P; Numanoglu A; Rode H; Kahn D; Millar AJ
    Transplant Proc; 2005 Mar; 37(2):1220-3. PubMed ID: 15848675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological complications of liver transplantation in pediatric patients: a single center experience.
    Erol I; Alehan F; Ozcay F; Canan O; Haberal M
    Pediatr Transplant; 2007 Mar; 11(2):152-9. PubMed ID: 17300494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
    Trotter JF; Wachs ME; Trouillot TE; Bak T; Kugelmas M; Kam I; Everson G
    Liver Transpl; 2001 May; 7(5):401-8. PubMed ID: 11349259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients.
    Takatsuki M; Chen CL; Chen YS; Wang CC; Lin CC; Yang CH; Yong CC; Liu YW
    Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Posttransplant complications in cardiac transplant recipients at National Cardiovascular Center].
    Kato T; Nakatani T; Kitamura S
    Kyobu Geka; 2007 Oct; 60(11):963-8. PubMed ID: 17926898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients.
    Burroughs TE; Swindle J; Takemoto S; Lentine KL; Machnicki G; Irish WD; Brennan DC; Schnitzler MA
    Transplantation; 2007 Apr; 83(8):1027-34. PubMed ID: 17452891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
    Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
    Ramos-Cebrián M; Torregrosa JV; Gutiérrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Risk Factors of mTORi-Associated Posttransplant Proteinuria.
    Lim LM; Kung LF; Kuo MC; Kuo HT
    Transplant Proc; 2018 Oct; 50(8):2535-2538. PubMed ID: 30316393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteinuria in an Otago diabetic population.
    Clarke VA; Hocken AG
    N Z Med J; 1980 Apr; 91(657):254-5. PubMed ID: 6930588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Proteinuria in diabetes].
    Janeczko D; Królewski AS
    Pol Tyg Lek; 1976 Feb; 31(8):317-9. PubMed ID: 1257147
    [No Abstract]   [Full Text] [Related]  

  • 37. Study of proteinuria in a community.
    Sarker MH; Chowdhury RI; Rashid HU
    Bangladesh Med Res Counc Bull; 1991 Oct; 17(2):41-7. PubMed ID: 1841593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Febrile proteinuria].
    Mori M
    Rinsho Byori; 1979; Suppl 36():85-93. PubMed ID: 430866
    [No Abstract]   [Full Text] [Related]  

  • 39. [Postural proteinuria].
    Okada T; Suzuki Y; Higuchi A; Konishi T
    Rinsho Byori; 1979; Suppl 36():63-74. PubMed ID: 430864
    [No Abstract]   [Full Text] [Related]  

  • 40. Proteinuria in children.
    Kelly NR; Ellis EN
    J Ark Med Soc; 1991 Oct; 88(5):219-23. PubMed ID: 1804838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.